| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |